Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial.
Travel Med Infect Dis
; 45: 102211, 2022.
Article
in En
| MEDLINE
| ID: mdl-34801714
Full text:
1
Database:
MEDLINE
Main subject:
Antimalarials
Type of study:
Clinical_trials
/
Guideline
/
Incidence_studies
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Travel Med Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2022
Type:
Article
Affiliation country:
United States